Skip to main content

Table 1 Patient, tumor, initial treatment characteristics

From: Impact of the initial site of metastases on post-recurrence survival for neuroendocrine cervical cancer

Parameters

N

%

Age, mean (range)

46 years (24–67 years)

 

Histology

 Small cell

71

80.7

 Pure

48

54.5

 Mixed with AdC

17

19.3

 Mixed with SqC or adenosquamous carcinoma

6

6.8

 Large cell

8

9.1

 Pure

6

6.8

 Mixed with small cell

2

2.3

 Neuroendocrine, NOS

9

10.2

 Pure

6

6.8

 Mixed with AdC

3

3.4

FIGO stage (2018)

 I

42

47.7

 II

9

10.2

 III

27

30.7

 IVa

2

2.3

 N/A

8

9.1

Tumor size

  ≤ 4.0 cm

41

46.6

  > 4.0 cm

19

21.6

 N/A

28

31.8

Depth of cervical stromal invasion

  < 1/3

22

25.0

  ≥ 1/3

57

64.8

 N/A

9

10.2

lymphovascular space invasion

 Yes

55

62.5

 No

12

13.6

 N/A

21

23.9

Pelvic lymph node metastasis

 Yes

29

33.0

 No

53

60.2

 N/A

6

6.8

Primary treatment

 Radiation

53

60.2

 Cycle of chemotherapy

 < 4

16

18.2

 ≥ 4

72

81.8

  1. N: Number